DPP-4 inhibition has beneficial effects on the heart after myocardial infarction-Reference-Cited by-同舟云学术

DPP-4 inhibition has beneficial effects on the heart after myocardial infarction

Published:2016-02 Issue: Volume:91 Page:72-80
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Kubota Akihiko,Takano Hiroyuki,Wang Haixiu,Hasegawa Hiroshi,Tadokoro Hiroyuki,Hirose Masanori,Kobara Yuka,Yamada-Inagawa Tomoko,Komuro Issei,Kobayashi Yoshio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference36 articles.

1. Chronic heart failure: contemporary diagnosis and management;Ramani;Mayo Clin. Proc.,2010

2. Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice;Ueda;J. Clin. Invest.,2010

3. The year in heart failure;Owens;J. Am. Coll. Cardiol.,2012

4. Treatment for chronic heart failure in the elderly: current practice and problems;Abete;Heart Fail. Rev.,2013

5. Dipeptidyl peptidase IV inhibition alters the hemodynamic response to angiotensin-converting enzyme inhibition in humans with the metabolic syndrome;Jackson;Hypertension,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of Health-Related Quality of Life in Outpatients with Myocardial Infarction;Journal of Multidisciplinary Healthcare;2024-05

2. Research status and development trends of post-myocardial infarction heart failure: a bibliometric analysis from 2012 to 2022;2024-01-22

3. Comparative effects of canagliflozin and sitagliptin in chronically ischemic myocardium;Vessel Plus;2024-01-12

4. Celebrating a Century of Insulin Discovery: A Critical Appraisal of the Emerging Alternative Insulin Delivery Systems;Current Drug Delivery;2023-07

5. Sitagliptin therapy improves myocardial perfusion and arteriolar collateralization in chronically ischemic myocardium: A pilot study;Physiological Reports;2023-06